Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Anesthesia and Postoperative Delirium in TAVI
jRCT1031250812Recruiting
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of remimazolam in aortic stenosis (AS), sponsored by none. Primary endpoint: Cumulative incidence of postoperative delirium (first 3 days). Started Apr 2026; status: recruiting.
02
Drugs
remimazolam
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on jRCT1031250812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031250812.